Tag: Investigational
Curadev Pharma gets FDA nod for phase-1 study of its cancer...
The company has received US-FDA's 'Study May Proceed' letter for its Investigational New Drug Application of CRD3874, an IV-Administered STING Agonist for the treatment of advanced/metastatic solid cancers